Base editing is a genome-editing approach that employs the CRISPR/Cas system to precisely install point mutations within the genome. A cytidine or adenosine deaminase enzyme is fused to a deactivated Cas and converts C to T or A to G, respectively. The diversified repertoire of base editors, varied in their Cas and deaminase proteins, provides a wide range of functionality. However, existing base-editors can only induce transition substitutions in a specified region determined by the base editor, thus, they are incompatible for many point mutations. Here, we present BE-FF (Base Editors Functional Finder), a novel computational tool that identifies suitable base editors to correct the translated sequence erred by a given single nucleotide variation. Even if a perfect correction of the single nucleotide variation is not possible, BE-FF detects synonymous corrections to produce the reference protein. To assess the potential of BE-FF, we analysed a database of human pathogenic point mutations and found suitable base editors for 60.9% of the transition mutations. Importantly, 19.4% of them were made possible only by synonymous corrections.
INTRODUCTION
Base editors (BEs) allow programmable genome editing in terms of a single nucleotide transition; purine to purine and pyrimidine to pyrimidine (A↔G and C↔T, respectively) (1, 2) .
The base editing technology employs the clustered regulatory interspaced short palindromic repeats (CRISPR)/Cas system to deliver a deaminase protein to precise genomic loci, as directed by the guide-RNA (gRNA) (3, 4) . The first BE (BE1) was introduced by Komor et al. (1) . This BE utilizes a cytidine deaminase enzyme fused to a catalytically deactivated Cas (dCas)(1), a Cas protein that contains mutations within its RuvC and HNH endonuclease domains (D10A and H840A) leading to the inability of the Cas protein to perform DNA cleavage. While the dCas protein lacks its endonuclease ability, it retains the competence to navigate through the genomic DNA to the designated locus (5) . Many more variants have been devised since then (table 1) and can be categorized to two main types: cytosine BEs (CBEs) which convert C to T and adenine BEs (ABEs) that convert A to G. The conversion by CBEs occurs via deamination of cytidine and the generation of uridine that acts as thymidine in base pairing (1) . ABEs utilize an adenosine deaminase enzyme to perform adenosine deamination, resulting in an inosine. During translation inosine acts as guanosine (6) , hence the activity of ABE yields an A to G transition (2) . By targeting the complementary strand, it is possible to indirectly convert G to A by CBE and T to C by ABE.
Taken together, CBEs and ABEs are capable of performing all the converting combinations of transition substitutions. While point mutations account for 58% of disease-causing genetic variants in humans, transition substitutions comprise 61% of the pathogenic point mutations (7) .
Notably, contrary to other CRISPR mediated gene editing methods, base editing does not involve DNA double-strand breaks (DSBs); thus, conferring a higher degree of safety as DSBs consequences include error-prone mutagenic repair pathways (alternative end joining and single-strand annealing)(8), p53 activation (9, 10) , large deletions and rearrangements (11) , integration of foreign genomes at the target site(12) and more.
Furthermore, compared to the homology directed repair (HDR) pathway that is thought to be the only precise resolution amongst DSB repair pathways, base editing is both more efficient(1) and allows editing of post-mitotic cells that are unable to undergo DSB-mediated HDR (13, 14) . A diverse toolbox of CBEs and ABEs is essential for developing treatments based on base editing for disease-associated point mutations. As natural Cas proteins are being discovered and synthetic variants are constantly being reported, so does the base editors toolbox expands with novel CBEs and ABEs. A pivotal consideration in gRNA design in general and base editing in particular, is the protospacer adjacent motif (PAM) limitation.
The PAM is a short sequence within the target DNA that has an essential role in DNA binding of the Cas protein. The motif must be flanking the target sequence as directed by the gRNA, downstream or upstream according to the Cas type (type II and type V, respectively) in order to induce DNA cleavage by the Cas protein (15) . As the PAM determines the binding site of the Cas protein to the DNA, it dictates the activity window region of the BE. Therefore, targeting a particular nucleotide is narrowed by the presence of a PAM in a precise distance from the activity window as determined by the BE. Each BE has a major activity window, where base editing occurs most efficiently, and minor activity window(s) in which the BE exhibits some degree of editing in significantly lower rates. All the target nucleotides (C or A) within the major activity window will undergo base editing. Consequently, if a target nucleotide is flanked by the same nucleotide, both will be edited and an unintended mutation may be introduced to the DNA (bystander base editing), instead of correction of the gene. In some cases, bystander base editing leads to a synonymous mutation compared to the intended sequence and may be accepted as a successful base editing outcome (e.g., ACTCTA [Thr,Leu] to ATTTTA [Ile, Leu] where threonine is the variant and isoleucine is the reference amino acid). A BE is comprised of the 3 basic elements of Cas and deaminase proteins and a linker fusing the 2 proteins. Thus, each BE has its own unique features: PAM compatibility, gRNA length, orientation relative to the PAM, affinity to the target sequence, target nucleotide (C or A), efficiency, activity window width and its distance from PAM, offtargets, protein size and more.
Since single-nucleotide variants (SNVs) naturally vary in genetic context, a diverse range of BEs is essential to precisely adjust to a given SNV. In base editing experimental design, one should consider the properties of the available BEs alongside their basic fit to perform transition of the target nucleotide. Due to the large selection of BEs (table 1) and the complexity of identifying proper BEs to a target site, the necessity of a computational tool arises. gRNA design and off-targets prediction tools are available for general purposes such as gene-knockouts (16) (17) (18) (19) . However, current tools use reference genomes as a template, while point mutations and patient-derived cells differ from the reference genome and therefore such tools are not suitable for designing base editing experiments for treating point mutations. Moreover, such tools are not customized for base editing and thus, do not take under consideration BEs' activity window and amino acids (AA) sequence. Existing tools that are base editing oriented, do not match suitable BEs for specific SNVs (20) , or lack the possibility to examine the translation outcome of the edited sequence (21) . To magnify the potential of base editing in treating as many cases as possible, the utilization of multiple Cas varieties and the ability to translate DNA sequences and compare the editing outcome are needed. To that end, we developed BE-FF, a tool that receives SNVs data, analyzes the reference and variant sequences and their translated outcomes and matches the suitable BEs out of 26 unique BEs. To assess the potential of base editing as a therapeutic approach for genetic diseases, we demonstrate the efficiency of BE-FF on a dataset of human pathogenic and likely-pathogenic SNVs. Furthermore, we established the BE-FF DB, a comprehensive database that includes pathogenic SNVs that can be edited via BE. While BEs are unable to reverse the DNA sequence of transversion mutations to match the reference sequence, editing a bystander nucleotide results in a proper AA substitution that matches the reference protein sequence ( figure 1d ). While the first two scenarios allow the correction of transition mutations, the last two scenarios also allow the correction of transversion mutations as they exploit codon degeneracy of several AAs. We further sought to assess the frequencies at which AA substitutions that were caused by transversion are reversible. Our results reveal that the following AA substitutions, caused by transversions, could be reversed via base editing: I>M, L>F, R>G, R>W and R>* (52%, 16%, 33%, 63% and 57% of the total of the transversion-derived mutations for each, respectively; 
RESULTS

A database of human pathogenic point mutations and their applicable BEs
BE-FF: Base Editors Functional Findera web tool that identifies BEs to correct SNVs
We established a web tool that receives SNV data and matches suitable BEs to correct the variation. The web tool receives data as a user manual input, fetches data by rsID or an uploaded batch mode file. Together with the flanking regions of the SNV in the DNA sequence, the reading frame of the sequence is utilized to translate the sequence. All 26 BEs (table 1) are available and examined to match the query. The tool does not limit the repertoire of BEs according to the base substitution. Thus, for any given SNV, an attempt to match any of the BEs is made to detect ones that perform precise correction as well as synonymous correction. The reverse-complement sequences are also considered for correction of the coding sequence. While a precise correction requires a full match of both the DNA and AA sequences, synonymous corrections are considered positive when only the AA sequences match and the DNA sequences do not. It is assumed that precise corrections are favorable in most cases over synonymous corrections and therefore the output divides the results into 2 parts, precise corrections and synonymous corrections. BE-FF supports user defined BE properties to allow researchers the utilization of novel or unpublished BEs.
Comparison to available tools
We compared BE-FF to two available base-editing design tools in several parameters and report the differences in a comparative table (table 2) . ABEs) that vary in their Cas proteins, deaminase enzymes and linkers and therefore provide a broad toolbox to perform base editing. The development of novel BEs contributes to the expansion of the base editing toolbox and advances base editing towards future therapeutics and research applications. We compared BE-FF to existing tools and find its utility valuable due to its compatibility with both CBEs and ABEs, the ability of translation and comparing the translated sequences to identify synonymous corrections, vast repertoire of BEs and the simple user interface. BE-FF is ideal for finding base editing solutions to repair specific point mutations. A recent study by Anzalone et al. reports a novel method termed Prime editing to make any type of edit (insertion, deletion, transition and transversion) mediated by the CRISPR/Cas system (39) . However, prime editing is more complex and requires additional refinements compared to base editing. Hence, base editing is considered favorable when possible. BE-FF is currently unable to provide off-targets insights and therefore, such offtargets assessment using complementary tools (e.g. CRISTA (16) , Cas-OFFinder(40), CCTop (19) and others) is suggested. For researchers intending to make use of the BE-FF database, in case the mutation of interest is missing, it is suggested to check whether it appears on the full dataset we used. Otherwise, it is recommended to use the web tool to analyze the variation of interest by SNP ID or manual input.
